Cargando…
The Pharmacogenomics of Anti-Hypertensive Therapy
Hypertension is a major public health problem, but measures to reduce blood pressure and thus cardiovascular risk are complicated by the high prevalence of treatment resistance, despite the availability of multiple drugs. Drug side-effects contribute considerably to suboptimal blood pressure control...
Autores principales: | Padmanabhan, Sandosh, Paul, Laura, Dominczak, Anna F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033952/ https://www.ncbi.nlm.nih.gov/pubmed/27713329 http://dx.doi.org/10.3390/ph3061779 |
Ejemplares similares
-
Genomic approaches to coronary artery disease
por: Padmanabhan, Sandosh, et al.
Publicado: (2010) -
Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022) -
Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020) -
Genome-Wide Association Studies of Hypertension: Light at the End of the Tunnel
por: Hastie, Claire E., et al.
Publicado: (2010) -
The hidden hand of chloride in hypertension
por: McCallum, Linsay, et al.
Publicado: (2015)